Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Prevention of Macrophage-Related Inflammatory Diseases by Allergina

  • Han, Sang-B. (Korea Research Institute of Bioscience and Biotechnology (KRIBB)) ;
  • Lee, Chang-W. (Korea Research Institute of Bioscience and Biotechnology (KRIBB)) ;
  • Park, Song-K. (Korea Research Institute of Bioscience and Biotechnology (KRIBB)) ;
  • Yoon, Won-K. (Korea Research Institute of Bioscience and Biotechnology (KRIBB)) ;
  • Moon, Jae-S. (Korea Research Institute of Bioscience and Biotechnology (KRIBB)) ;
  • Lee, Ki-H. (Korea Research Institute of Bioscience and Biotechnology (KRIBB)) ;
  • Kim, Hyung-C. (Korea Research Institute of Bioscience and Biotechnology (KRIBB)) ;
  • Kim, Hwan-M. (Korea Research Institute of Bioscience and Biotechnology (KRIBB))
  • Published : 2003.04.01
Download PDF
⟨ Previous Next ⟩

Abstract

The oriental herbal combination allergina has been shown to inhibit allergic inflammation. In the present study, we demonstrate that the oral administration of allergina markedly inhibits the progression of inflammatory diseases, such as graft-versus-host diseases (in the allogeneic bone marrow transplantation and the parent-into-F1 transplantation models), collagen-induced arthritis and sheep red blood cell-induced delayed type hypersensitivity. The immunosuppressive activity of allergina in vivo appears to be associated, at least in part, with the inhibition of tumor necrosis factor-a production. In conclusion, our results suggest that allergina could be useful as a immunosuppressive agent for the treatment of macrophage-related inflammatory disease.

Keywords

References

  1. Conway, J. G., Andrews, R. C., Beaudet, B., Bickett, D. M., Boncek, V., Brodie, T. A., Clark, R. L., Crumrine, R. C., Leenitzer, M. A., McDougald, D. L., Han, B., Hedeen, K., Lin, P., Milla, M., Moss, M., Pink, H., Rabinowitz, M. H., Tippin, T., Scates, P. W., Selph, J., Stimpson, S. A., Warner, J., and Becherer, J. D., Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases. J. Pharmacol. Exp. Ther., 298, 900-908 (2001)?⨀ᤀĀ胝?⨀ᤀĀ僥?⨀ऀĀꃍ?⨀Ā삽?⨀栀Ā䢄⨀؀Ā좄⨀਀Ā䢅⨀܀Ā夅돀聡ಗ⨀塨?⨀졫ಗ⨀ㄅ돐ಗ⨀쁖잖⨀࡬ಗ⨀अ덐ᡬಗ⨀ࠅ晵瑵牥〴　㈰〹ⴱㄭㄳ섂돀⡝ಗ⨀塨?⨀ᣋ?⨀餂돐ꡖ잖⨀ꡖ잖⨀䃋?⨀㤀덀僋?⨀㠀᠀ࡿ⨀碥잖⨀㤂돐桧ಗ⨀?⨀?⨀뢥잖⨀䤉덐좥잖⨀䠉⠉Ā䖽ꡞ匈ĀĀĀ글ꠄ잖⨀Ā잖⨀ÿ✀䡪ಗ⨀ಗ⨀䄇䀀??㤇돀邱஗⨀塨?⨀联잖⨀쀴җ⨀餀덀뢱஗⨀頀偪ಗ⨀联잖⨀
  2. Gongora, L., Manez, S., Giner, R. M., Recio, M. C., and Rios, J. L., On the activity of trifluoperazine and palmitoylcarnitine in mice: delayed hypersensitivity models. Life Sci., 66, L183-188 (2000)
  3. Gorgun, G., Miller, K. B., and Foss, F. M., Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease. Blood, 100, 941-947 (2002) https://doi.org/10.1182/blood-2002-01-0068
  4. Han, S. B., Park, S. H., Jeon, Y. J., Kim, Y. K., Kim, H. M., and Yang, K. H., Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen- induced arthritis. J. Pharmacol. Exp. Ther., 299, 415-425 (2001)
  5. Jeong, H. J., Hong, S. H., Kim, S. C., Park, E. J., Jang, C. H., Kim, K. S., and Kim, H. M., Effects of Allergina on the treatment of otitis media with effusions. Inflammation, 26, 89-95 (2002) https://doi.org/10.1023/A:1014888328482
  6. Jeong, H. J., Jung, S. W., Kim, K. S., Lim, J. P., Park, E. J., Hwang, W. J., Jang, C. H., and Kim, H. M., Effect of allergina on mast cell-mediated allergic reactions. Immunopharmacol. Immunotoxicol., 23, 627-637 (2001)
  7. Lu, Y., Sakamaki, S., Kuroda, H., Kusakabe, T., Konuma, Y., Akiyama, T., Fujimi, A., Takemoto, N., Nishiie, K., Matsunaga, T., Hirayama, Y., Kato, J., Kon, S., Kogawa, K., and Niitsu, Y., Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603. Blood, 97, 1123-1130 (2001) https://doi.org/10.1182/blood.V97.4.1123
  8. Luross, J. A. and Williams, N. A., The genetic and immunopathological processes underlying collagen-induced arthritis. Immunol., 103, 407-416 (2001) https://doi.org/10.1046/j.1365-2567.2001.01267.x
  9. Okamoto, I., Iwaki, K., Koya-Miyata, S., Tanimoto, T., Kohno, K., Ikeda, M., and Kurimoto, M., The flavonoid Kaempferol suppresses the graft-versus-host reaction by inhibiting type 1 cytokine production and CD8+ T cell engraftment. Clin. Immunol., 103, 132-144 (2002) https://doi.org/10.1006/clim.2001.5187
  10. Taylor, P. A., Friedman, T. M., Korngold, R., Noelle, R. J., and Blazar, B. R., Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell. Blood, 99, 4601-4609 (2002) https://doi.org/10.1182/blood.V99.12.4601
  11. Wagner, J. E., Donnenberg, A. D., Noga, S. J., Cremo, C. A., Gao, I. K., Yin, H. J., Vogelsang, G. B., Rowley, S., Saral, R., and Santos, G. W., Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: results of a phase I clinical trial. Blood, 72, 1168-1176 (1988)
  12. Weisdorf, D., Haake, R., Blazar, B., Miller, W., McGlave, P., Ramsay, N., Kersey, J., and Filipovich, A., Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome. Blood, 75, 1024-1030 (1990)